Archimed Acquires Irrimax to Expand Anti-Microbial Wound Care Solutions

02 Sep, 2024

Archimed Acquires Irrimax to Expand Anti-Microbial Wound Care Solutions

France-based private value firm Archimed has obtained Irrimax Enterprise, counting its holding company Development Advances, for an undisclosed whole. Irrimax, a U.S.-based company established in 2003, specializes in creating and showcasing Irrisept Antimicrobial Wound Lavage, a wound water system arrangement. This securing will empower Irrimax to broaden its item run and extend its worldwide reach, tapping into a developing advertise expected to see critical development in the medium term.

Irrimax works in the segments of Surgery & Working Consumables and Wound Care, both distinguished as need venture ranges by Archimed’s exclusive examination device, MedSeg. MedSeg assesses over 430 sub-segments of the worldwide healthcare industry to direct venture choices. Archimed's securing was upheld by a few advisors: Foley & Lardner given lawful guide, Bain & Co conducted key due perseverance, and PwC overseen monetary and assess contemplations. Harris Williams exhorted Irrimax, with Eversheds Sutherland and Lord & Spalding serving as lawful advisors to Irrimax management.

The procurement was completed through Archimed’s MED Stage II support, which accomplices with driving companies in the mid-cap worldwide healthcare advertise. This support bolsters companies in development, capacity development, item line development, and advertise passage. With Irrimax, MED Stage II presently contributes in five stage companies, counting Instem, Natus Neuro, Natus Tangible, and Plasmid Manufacturing plant. All speculations are first-time buyouts sourced through Archimed’s MedDiscover approach, a framework outlined to distinguish and lock in with best companies in key healthcare segments.